Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes.
bile acids
fibroblast growth factor-19
glucagon-like peptide-1
postprandial glycaemia
type 2 diabetes
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
21
02
2022
received:
19
01
2022
accepted:
01
03
2022
pubmed:
4
3
2022
medline:
22
4
2022
entrez:
3
3
2022
Statut:
ppublish
Résumé
To determine the serum bile acid (BA) response to 75-g oral glucose in individuals without diabetes, and whether this is attenuated in patients with 'early' type 2 diabetes (T2D) and related to the glycaemic response at 2 hours in either group. Forty newly diagnosed, treatment-naïve Han Chinese T2D subjects and 40 age-, gender-, and body mass index-matched controls without T2D ingested a 75-g glucose drink after an overnight fast. Plasma glucose and serum concentrations of total and individual BAs, fibroblast growth factor-19 (FGF-19), total glucagon-like peptide-1 (GLP-1), and insulin, were measured before and 2 hours after oral glucose. Fasting total BA levels were higher in T2D than control subjects (P < .05). At 2 hours, the BA profile exhibited a shift from baseline in both groups, with increases in conjugated BAs and/or decreases in unconjugated BAs. There were increases in total BA and FGF-19 levels in control (both P < .05), but not T2D, subjects. Plasma glucose concentrations at 2 hours related inversely to serum total BA levels in control subjects (r = -0.42, P = .006). Total GLP-1 and the insulin/glucose ratio were increased at 2 hours in both groups, and the magnitude of the increase was greater in control subjects. The serum BA response to a 75-g oral glucose load is attenuated in patients with 'early' T2D, as is the secretion of FGF-19 and GLP-1, while in individuals without T2D it correlates with 2-hour plasma glucose levels. These observations support a role for BAs in the regulation of postprandial glucose metabolism.
Identifiants
pubmed: 35238131
doi: 10.1111/dom.14683
pmc: PMC9540586
doi:
Substances chimiques
Bile Acids and Salts
0
Blood Glucose
0
Insulin
0
Fibroblast Growth Factors
62031-54-3
Glucagon-Like Peptide 1
89750-14-1
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1132-1142Informations de copyright
© 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Diabetes. 2015 Jul;64(7):2513-25
pubmed: 25677912
Metabolism. 2019 Apr;93:25-32
pubmed: 30658059
Nat Commun. 2015 Jul 21;6:7715
pubmed: 26197299
Nat Commun. 2021 Mar 5;12(1):1487
pubmed: 33674561
Front Neurosci. 2015 Jun 03;9:199
pubmed: 26089773
Gastroenterology. 2019 Mar;156(4):1041-1051.e4
pubmed: 30445014
J Clin Endocrinol Metab. 2013 Apr;98(4):E718-22
pubmed: 23418316
J Clin Endocrinol Metab. 2016 May;101(5):1935-44
pubmed: 26684275
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9
pubmed: 25470627
J Lipid Res. 2011 Aug;52(8):1561-8
pubmed: 21642744
Diabetes. 2014 Aug;63(8):2776-87
pubmed: 24647737
J Lipid Res. 2012 Oct;53(10):2231-2241
pubmed: 22822028
Ann Clin Biochem. 2010 Sep;47(Pt 5):482-4
pubmed: 20595403
J Intern Med. 2017 May;281(5):507-517
pubmed: 28261926
Diabetes Care. 2015 Feb;38(2):243-8
pubmed: 25504029
Diabetes Obes Metab. 2022 Jun;24(6):1132-1142
pubmed: 35238131
Int J Obes (Lond). 2017 May;41(5):789-792
pubmed: 28104918
EBioMedicine. 2020 May;55:102759
pubmed: 32344198
Cell Metab. 2019 Nov 5;30(5):855-864.e3
pubmed: 31588013
PLoS One. 2011;6(11):e25006
pubmed: 22110577
Gastroenterology. 2017 May;152(7):1679-1694.e3
pubmed: 28214524
Clin Chem. 2016 Sep;62(9):1211-9
pubmed: 27471037
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1643-e1652
pubmed: 34791325
Diabetes Obes Metab. 2020 Feb;22(2):141-148
pubmed: 31468642
Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G413-9
pubmed: 23275610
Prog Lipid Res. 2021 Apr;82:101094
pubmed: 33636214
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2020-30
pubmed: 16037564
J Lipid Res. 2010 Apr;51(4):832-42
pubmed: 19965590
Eur J Endocrinol. 2014 Oct;171(4):407-19
pubmed: 24986531
J Pharm Biomed Anal. 2016 Nov 30;131:473-481
pubmed: 27689719
Nat Rev Endocrinol. 2019 Dec;15(12):701-712
pubmed: 31616073
Cell Metab. 2009 Sep;10(3):167-77
pubmed: 19723493
Diabetes Care. 2021 Feb;44(2):499-510
pubmed: 33355246
Nutrients. 2021 Mar 28;13(4):
pubmed: 33800566
Handb Exp Pharmacol. 2016;233:137-71
pubmed: 25903418
Ann Clin Biochem. 2013 Jul;50(Pt 4):360-4
pubmed: 23771134
United European Gastroenterol J. 2014 Jun;2(3):216-25
pubmed: 25360305
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
pubmed: 10902785
Obes Surg. 2016 Jul;26(7):1565-75
pubmed: 26464241
Endocrinology. 2015 Nov;156(11):3961-70
pubmed: 26280129
Handb Exp Pharmacol. 2019;256:51-72
pubmed: 31230143
Essays Biochem. 2016 Dec 15;60(5):409-418
pubmed: 27980091
Pharmaceutics. 2020 Aug 21;12(9):
pubmed: 32825608
J Clin Endocrinol Metab. 2016 Aug;101(8):3002-9
pubmed: 27270475